The ongoing impact of COVID-19 on clinical research
Almost immediately after news reports confirmed that COVID-19 was spreading around the globe, companies involved in clinical research started wondering “What...
Angela De Martini is a vice president in CRA’s Life Sciences Practice, specializing in pharmaceuticals, medical devices, and medical technology.
Angela supports clients in the pharmaceutical, biotech and medical device industries globally. She collaborates with client teams on a broad range of strategic topics including commercial, medical affairs, R&D, as well as portfolio and corporate strategy. Prior to CRA’s acquisition of C1 Consulting in 2017, she was a director at C1 Consulting and held senior positions at a-connect and Navigant (formerly Easton Associates).